You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The decision comes amid a general slowdown in the market, yet also showcases the continued appeal of ancestry-related applications.
Ancestry will focus more on family history and genetic genealogy, and called the move a "strategic but difficult decision."
The New York-based multinational investment company will acquire Ancestry from current stakeholders Silver Lake, Spectrum Equity, Permira, and others.
The next iteration of Ancestry's Health experience seeks to provide customers with actionable information about certain commonly inherited health conditions.
In the study, called Coronagenes, the team aims to identify genes that influence the risk of developing COVID-19 and affect disease severity.
Stat News offers ways consumer genetic testing companies could address racial disparities.
Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.
Data collected from volunteers will be used in a genome-wide association study to better understand COVID-19.
The Helsinki-based firm is making its panel available for free to people who already have been genotyped by consumer genomics services or biobanks.
The Wall Street Journal reports on gaps in COVID-19 testing affecting less affluent urban areas and rural locations.
According to NBC News, new SARS-CoV-2 variants are making it harder for researchers to model the course of the pandemic.
The New York Times reports that experts say President Joe Biden's goal of vaccinating 1 million people a day in the US in the next 100 days is too low a bar.
In Science this week: single-cell lineage tracing technique applied to study lung cancer metastasis, and more.